{"disease":{"id":"watchman-laa-closure-device","name":"watchman laa closure device"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03539055","title":"Efficacy of Short Term Dabigatran Etexilate Followed by Aspirin Monotherapy After LAA (Left Atrial Appendage) Device Closure (the DEA-LAA Study).","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}